These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 830773)

  • 81. Reduction of contact factors in sickle cell disease.
    Gordon EM; Klein BL; Berman BW; Strandjord SE; Simon JE; Coccia PF
    J Pediatr; 1985 Mar; 106(3):427-30. PubMed ID: 3844465
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Molecular assembly in the contact phase of the Hageman factor system.
    Cochrane CG; Griffin JH
    Am J Med; 1979 Oct; 67(4):657-64. PubMed ID: 386794
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Mechanism of activation of the kallikrein-kinin system in plasma of patients with atopic allergic diseases.
    Dotsenko VL; Nenasheva NM; Neshkova EA; Morozova NA; Yarovaya GA
    Adv Exp Med Biol; 1989; 247B():515-21. PubMed ID: 2610090
    [No Abstract]   [Full Text] [Related]  

  • 84. Prekallikrein activator (Hageman factor fragment) in human plasma fractions.
    Kuwahara SS
    Transfusion; 1980; 20(4):433-9. PubMed ID: 6773191
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Interaction between factor XII (Hageman factor), high molecular weight kininogen and prekallikrein.
    Chan JY; Habal FM; Burrowes CE; Movat HZ
    Thromb Res; 1976 Nov; 9(5):423-33. PubMed ID: 996830
    [No Abstract]   [Full Text] [Related]  

  • 86. [Factor XII (HAGEMAN FACTOR)].
    Kase F; Klír P; Pospísil J; Poucková P
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1978; 105(1):1-19. PubMed ID: 77809
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Determination of Hageman factor (HG, factor XII) and plasma prekallikrein (Fletcher factor) by radioimmunoassays.
    Saito H
    Adv Exp Med Biol; 1979; 120A():165-72. PubMed ID: 573961
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [Dynamics of components of the kallikrein-kinin system in the arterial and venous blood and cerebrospinal fluid of patients with severe cranio-cerebral injuries].
    Valeev IK; Raĭzman SM; Tsibul'kin AP
    Zh Vopr Neirokhir Im N N Burdenko; 1979; (1):27-30. PubMed ID: 425774
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Effect of surfaces on fluid-phase prekallikrein activation.
    Scott CF; Kirby EP; Schick PK; Colman RW
    Blood; 1981 Mar; 57(3):553-60. PubMed ID: 6906235
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Mechanism and significance of kinin formation in nephrotic syndrome.
    Nakamura K; Kazama M; Morioka M; Tahara C; Abe T
    Adv Exp Med Biol; 1986; 198 Pt B():253-62. PubMed ID: 3028075
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Factor XII, kininogen and plasma prekallikrein in abnormal pregnancies.
    Sugi T; Makino T
    Curr Drug Targets; 2005 Aug; 6(5):551-7. PubMed ID: 16026275
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Human plasma prekallikrein (Fletcher factor) clotting activity and antigen in health and disease.
    Saito H; Poon MC; Vicic W; Goldsmith GH; Menitove JE
    J Lab Clin Med; 1978 Jul; 92(1):84-95. PubMed ID: 659966
    [TBL] [Abstract][Full Text] [Related]  

  • 93. [Characteristics of changes in the kinin system of blood in hypertensive disease].
    Chernova NA; Nekrasova AA; Lantsberg LA
    Kardiologiia; 1976 May; 16(5):46-51. PubMed ID: 1084940
    [TBL] [Abstract][Full Text] [Related]  

  • 94. A comparison of the effects of intravenous serotonin and dextran on the levels of factor XII, prekallikrein and plasminogen in rat plasma.
    Berstad J
    Acta Pharmacol Toxicol (Copenh); 1980 Apr; 46(4):314-20. PubMed ID: 6154406
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Contact activation factors in plasma from women using oral contraceptives--increased levels of factor XII, kinin-free high molecular weight kininogen and acetone-activated kallikrein.
    Hoem NO; Johannesen S; Hauge G; Rud AC; Sandem S; Briseid K
    Thromb Res; 1991 Nov; 64(4):427-34. PubMed ID: 1788829
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Hageman factor dependent pathway in local vascular permeability enhancement.
    Yamamoto T; Kozono K; Tsuruta J; Cochrane CG; Kambara T
    Adv Exp Med Biol; 1986; 198 Pt B():45-52. PubMed ID: 3812107
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Arginine esterase in cerebrospinal fluid and pro-arginine esterase in plasma from patients with migraine.
    Briseid K; Falkum A; Qvigstad EK; Stien R
    Acta Neurol Scand; 1976 Oct; 54(4):301-11. PubMed ID: 973552
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Study of TAMe (p-tosyl-L-arginine methyl ester) esterase activity of bovine plasma.
    Claxton J; Black WD; Gentry PA
    Am J Vet Res; 1978 Jul; 39(7):1235-8. PubMed ID: 677544
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Kinin-generating cascade in advanced cancer patients and in vitro study.
    Matsumura Y; Maruo K; Kimura M; Yamamoto T; Konno T; Maeda H
    Jpn J Cancer Res; 1991 Jun; 82(6):732-41. PubMed ID: 1906858
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Plasma prekallikrein, kallikrein inhibitors, kininogen and lipids during gemfibrozil treatment in type II dyslipidaemia.
    Torstila I; Kaukola S; Manninen V; Virtamo J; Mälkönen M
    Acta Med Scand Suppl; 1982; 668():123-9. PubMed ID: 6188330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.